Table 4 Association of PHKA1 expression levels with clinicopathological characteristics in patients with DLBCL
Characteristic | Total No | Low Expression, No. (%) | High Expression, No. (%) | Pearson χ2 | p-value |
|---|---|---|---|---|---|
Gender | Â | Â | Â | 0.117 | 0.733 |
 Male | 55 | 33 (60.0) | 22 (40.0) |  |  |
 Female | 49 | 31 (63.3) | 18 (36.7) | ||
Age (year) | Â | Â | Â | 3.254 | 0.071 |
 ≤ 60 | 56 | 30 (53.6) | 26 (46.4) |  |  |
 > 60 | 48 | 34 (70.8) | 14 (29.2) | ||
B symptoms | Â | Â | Â | 0.125 | 0.723 |
 No | 84 | 51 (60.7) | 33 (39.3) |  |  |
 Yes | 20 | 13 (65.0) | 7 (35.0) | ||
Ann Arbor stage | Â | Â | Â | 0.313 | 0.576 |
 I or II | 76 | 48 (63.2) | 28 (36.8) |  |  |
 III or IV | 28 | 16 (57.1) | 12 (42.9) | ||
Hb level (g/L) | Â | Â | Â | 0.009 | 0.924 |
 ≥ 120 | 63 | 39 (61.9) | 24 (38.1) |  |  |
 < 120 | 41 | 25 (61.0) | 16 (39.0) | ||
LDH level (g/L) | Â | Â | Â | 0.924 | 0.336 |
 Normal | 51 | 29 (56.9) | 22 (43.1) |  |  |
 Elevated | 53 | 35 (66.0) | 18 (34.0) | ||
IPI score | Â | Â | Â | 0.556 | 0.456 |
 0–2 | 55 | 32 (58.2) | 23 (41.8) |  |  |
 3–5 | 49 | 32 (65.3) | 17 (34.7) |  |  |